Published in Blood Weekly, February 19th, 2009
"HRQOL was assessed in 128 stable KTP and 102 chronic kidney disease patients (CKDP) using the SF-36 health survey. The 2 groups were matched for age, sex, sociodemographic conditions, and renal function, the only difference being that KTP had experienced hemodialysis treatments before...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.